S. Vukelja

1.2k total citations
30 papers, 911 citations indexed

About

S. Vukelja is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, S. Vukelja has authored 30 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 6 papers in Genetics and 6 papers in Cancer Research. Recurrent topics in S. Vukelja's work include Cancer Treatment and Pharmacology (11 papers), HER2/EGFR in Cancer Research (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). S. Vukelja is often cited by papers focused on Cancer Treatment and Pharmacology (11 papers), HER2/EGFR in Cancer Research (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). S. Vukelja collaborates with scholars based in United States, Italy and India. S. Vukelja's co-authors include Joyce O’Shaughnessy, Stephen E. Jones, Frankie A. Holmes, Israel Wiznitzer, Michael A. Savin, Luís Meza, Bertrand C. Liang, J. Shogan, Lister Hill and Malcolm A.S. Moore and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and European Journal of Cancer.

In The Last Decade

S. Vukelja

30 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Vukelja United States 10 707 370 179 109 106 30 911
Pamela Lockbaum United States 9 763 1.1× 246 0.7× 167 0.9× 208 1.9× 56 0.5× 13 983
T. Hakes United States 11 880 1.2× 152 0.4× 125 0.7× 61 0.6× 188 1.8× 18 1.4k
I. E. Smith United Kingdom 12 503 0.7× 200 0.5× 217 1.2× 46 0.4× 45 0.4× 27 848
Antonio Durando Italy 16 516 0.7× 146 0.4× 318 1.8× 29 0.3× 43 0.4× 42 976
Theodore A. Vandenberg Canada 12 463 0.7× 113 0.3× 206 1.2× 21 0.2× 40 0.4× 26 774
Encarna Adrover Spain 14 864 1.2× 113 0.3× 297 1.7× 29 0.3× 84 0.8× 40 1.1k
W. Li China 11 684 1.0× 158 0.4× 372 2.1× 42 0.4× 48 0.5× 47 981
WP Peters United States 11 467 0.7× 117 0.3× 102 0.6× 507 4.7× 20 0.2× 24 827
Eleni Timotheadou Greece 17 616 0.9× 92 0.2× 303 1.7× 23 0.2× 34 0.3× 76 1.0k
Miguel H. Bronchud Spain 11 327 0.5× 181 0.5× 126 0.7× 129 1.2× 13 0.1× 33 574

Countries citing papers authored by S. Vukelja

Since Specialization
Citations

This map shows the geographic impact of S. Vukelja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Vukelja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Vukelja more than expected).

Fields of papers citing papers by S. Vukelja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Vukelja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Vukelja. The network helps show where S. Vukelja may publish in the future.

Co-authorship network of co-authors of S. Vukelja

This figure shows the co-authorship network connecting the top 25 collaborators of S. Vukelja. A scholar is included among the top collaborators of S. Vukelja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Vukelja. S. Vukelja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Osborne, Cynthia, Charles F. Eisenbeis, Frankie A. Holmes, et al.. (2017). Ixabepilone and Carboplatin for Hormone Receptor Positive/HER2-neu Negative and Triple Negative Metastatic Breast Cancer. Clinical Breast Cancer. 18(1). e89–e95. 7 indexed citations
2.
Braiteh, Fadi S., Jeff P. Sharman, Donald Richards, et al.. (2014). Effect of clinical NGS-based cancer genomic profiling on physician treatment decisions in advanced solid tumors.. Journal of Clinical Oncology. 32(15_suppl). 11109–11109. 1 indexed citations
3.
Bendell, Johanna C., John Nemunaitis, S. Vukelja, et al.. (2011). Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine As Second- or Third-Line Therapy in Patients With Metastatic Colorectal Cancer. Journal of Clinical Oncology. 29(33). 4394–4400. 81 indexed citations
4.
Pippen, John, Devchand Paul, Christopher Stokoe, et al.. (2011). Randomized, phase III study of adjuvant doxorubicin plus cyclophosphamide (AC) → docetaxel (T) with or without capecitabine (X) in high-risk early breast cancer: Exploratory Ki-67 analyses.. Journal of Clinical Oncology. 29(15_suppl). 500–500. 9 indexed citations
5.
Burris, H.A., S. Vukelja, Ian E. Krop, et al.. (2009). 5020 Pharmacokinetics (PK), safety, and efficacy of trastuzumab (T)-DM1, a HER2 antibody-drug conjugate (ADC), in patients with HER2+ metastatic breast cancer (MBC): phase I and phase II trial results. European Journal of Cancer Supplements. 7(2). 266–267. 1 indexed citations
6.
Vukelja, S., Hope S. Rugo, C Vogel, et al.. (2009). A phase II study of trastuzumab-DM1, a first-in-class HER2 antibody-drug conjugate, in patients with HER2+ metastatic breast cancer.. Cancer Research. 69(2_Supplement). 33–33. 20 indexed citations
7.
Cunningham, Casey, John Nemunaitis, Neil Senzer, et al.. (2007). Effect of clofarabine on lymphocyte populations in patients treated for solid tumors. Journal of Clinical Oncology. 25(18_suppl). 21134–21134. 4 indexed citations
8.
Jones, Stephen E., James Cantrell, S. Vukelja, et al.. (2005). The effect of tamoxifen (T) or exemestane (E) on bone mineral density (BMD) after 1 year of adjuvant treatment of postmenopausal women with early breast cancer. Journal of Clinical Oncology. 23(16_suppl). 610–610. 11 indexed citations
9.
O’Shaughnessy, Joyce, et al.. (2004). Phase II Study of Trastuzumab plus Gemcitabine in Chemotherapy-Pretreated Patients with Metastatic Breast Cancer. Clinical Breast Cancer. 5(2). 142–147. 73 indexed citations
10.
Cunningham, Casey, John Nemunaitis, Neil Senzer, et al.. (2004). Clofarabine administered weekly to adult patients with advanced solid tumors in a phase I dose-finding study. Journal of Clinical Oncology. 22(14_suppl). 3115–3115. 1 indexed citations
11.
Cunningham, Casey, Sunil Chada, James A. Merritt, et al.. (2004). Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study. Molecular Therapy. 11(1). 149–159. 166 indexed citations
12.
Cunningham, Casey, John Nemunaitis, Neil Senzer, et al.. (2004). Clofarabine administered weekly to adult patients with advanced solid tumors in a phase I dose-finding study. Journal of Clinical Oncology. 22(14_suppl). 3115–3115. 1 indexed citations
13.
14.
Vukelja, S., Vladimir Moiseyenko, Robert Leonard, et al.. (2001). Xeloda (capecitabine) plus docetaxel combination therapy in locally advanced/metastatic breast cancer: Latest results. Breast Cancer Research and Treatment. 69(3). 6 indexed citations
15.
Leonard, Robert, Guadalupe Cervantes, Weng‐Onn Lui, et al.. (2001). Survival update of so14999 a large phase III trial of capecitabine/doxetaxel combination therapy vs docetaxel monotherapy in patients with locally advanced (LABC) or metastatic breast cancer (MBC). European Journal of Cancer. 37. S151–S151. 5 indexed citations
16.
Sharma, Sachit, S. Vukelja, & Shailesh C. Kadakia. (1997). Gilbert's syndrome co-existing with and masking hereditary spherocytosis. Annals of Hematology. 74(6). 287–289. 20 indexed citations
17.
Vukelja, S., et al.. (1995). Bilateral Synchronous Testicular Germ Cell Cancer. Southern Medical Journal. 88(3). 305–308. 7 indexed citations
18.
McCarty, Matthew J., S. Vukelja, E. A. Sausville, et al.. (1994). Lymphomatoid Papulosis Associated with Ki-1-Positive Anaplastic Large Cell Lymphoma.. 74(11). 3051–3058. 10 indexed citations
19.
Vukelja, S., et al.. (1992). Hypercoagulable states. Postgraduate Medicine. 91(3). 117–132. 4 indexed citations
20.
Vukelja, S., Jayashree Krishnan, Frank T. Ward, & Janice Redmond. (1990). Synchronous Hodgkinʼs Disease and Myelofibrosis Terminating With Granulocytic Sarcoma and Acute Megakaryocytic Leukemia. Southern Medical Journal. 83(11). 1317–1320. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pamela Lockbaum Breakdown of academic impact, for papers by T. Hakes Breakdown of academic impact, for papers by I. E. Smith Breakdown of academic impact, for papers by Antonio Durando Breakdown of academic impact, for papers by Theodore A. Vandenberg Breakdown of academic impact, for papers by Encarna Adrover Breakdown of academic impact, for papers by W. Li Breakdown of academic impact, for papers by WP Peters Breakdown of academic impact, for papers by Eleni Timotheadou Breakdown of academic impact, for papers by Miguel H. Bronchud
Rankless by CCL
2026